Yusei Shinohara, Yuki Komiya, Kashin Morimoto, Yoshio Endo, Minoru Terashima, Takeshi Suzuki, Takahisa Takino, Itasu Ninomiya, Hisatsugu Yamada, Yoshihiro Uto. Development of UTX-143, a selective sodium-hydrogen exchange subtype 5 inhibitor, using amiloride as a lead compound. Bioorganic & medicinal chemistry. 2024. 99. 117603-117603
Gerelsuren Batbayar, Akihiko Ishimura, Hanbing Lyu, Sasithorn Wanna-Udom, Makiko Meguro-Horike, Minoru Terashima, Shin-Ichi Horike, Takahisa Takino, Takeshi Suzuki. ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation. Biochemical and biophysical research communications. 2023. 669. 19-29
Kusuma Suphakhong, Minoru Terashima, Sasithorn Wanna-Udom, Risa Takatsuka, Akihiko Ishimura, Takahisa Takino, Takeshi Suzuki. m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells. The Journal of biological chemistry. 2022. 298. 11. 102554-102554
Hirari Yamahana, Yuki Komiya, Takahisa Takino, Yoshio Endo, Hisatsugu Yamada, Chikako Asada, Yoshihiro Uto. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors. Chemical and Pharmaceutical Bulletin. 2021. 69. 10. 1017-1028
Yusei Shinohara, Itasu Ninomiya, Yoshio Endo, Takahisa Takino, Yoshihiro Uto. Development of a Novel Amiloride Derivative as a Na plus /H plus exchanger 5 selective inhibitor. CANCER SCIENCE. 2021. 112. 912-912
Hirari Yamahana, Takahisa Takino, Yoshio Endo, Takeshi Suzuki, Yoshihiro Uto. Development of a Novel Celecoxib Derivative UTX-121 as an Antimetastatic Agent. CANCER SCIENCE. 2021. 112. 695-695
日本生化学会
, 日本結合組織学会
, 日本がん転移学会
, 日本癌学会
, Japanese Biochemical Society
, Japanese Society for Connective Tissue Research
, Japanese Association for Metastasis Research Society
, Japanese Cancer Association